1. Anderson J, Krivit W, Thompson J, Chilcote R, Pysemany A, Hammond D (1980) Cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. Current Chemotherapy and Infectious Disease. Proceedings of the 11th I.C.C. and the 19th ICAAC American Society of Microbiology, vol II:1567
2. Barnett Ch J, Cullinam GJ, Gerzon K, Hoving RC, Jones WE, Newlon WM, Poore GA, Robison RL, Sweeney MJ, Todd GC (1978) Structure-activity relationship of dimeric Catharantus alkaloids. 1-Deacetyl-vinblastine amide (Vindesine) sulfate. J Med Chem 21 (1):88
3. Bayssas M, Gouveia J, Ribaud P, Musset M, de Vassal F, Misset J-L, Machover D, Belpomme D, Schwarzenberg L, Jasmin C, Hayat M, Mathé G (1979) Phase II trial with vindesine for regression induction in patients with leukemias and hematosarcomas. Cancer Chemother Pharmacol 2:247
4. Bayssas M, Gouveia J, de Vassal F, Misset J-L, Machover D, Schwarzenberg L, Schneider M, Mathé G (1979) Phase I clinical trials with Vindesine for remission induction in leukemias and lymphomas. Apparent absence of cross-resistance with vincristine. Proc 70th Meeting Am Assoc Cancer Res 20 (192):48
5. Dyke RW, Nelson RL (1977) Phase I anticancer agents: Vindesine (desacetyl vinblastine amide sulfate). Cancer Treat Rev 4:135